Varicose Vein Treatment Market by Procedure (Injection Sclerotherapy, Endovenous Ablation, Surgical Ligation and Stripping), Product (sclerotherapy injection, Ablation devices and others) and End User (Hospitals, Clinics, and Ambulatory centers): Global Opportunity Analysis and Industry Forecast, 2018 - 2025

1.1. Report description

1.2. Key benefits for stakeholders

1.3. Key Market Segments

1.3.1. List of key players profiled in the report:

1.4. Research methodology

1.4.1. Secondary research

1.4.2. Primary research

1.4.3. Analyst tools and models

Chapter: 2: EXECUTIVE SUMMARY

2.1. Key findings of the study

2.2. CXO perspective

Chapter: 3: MARKET OVERVIEW

3.1. Market definition and scope

3.2. key findings

3.2.1. Top investment pockets

3.2.2. Top player positioning

3.3. Market dynamics

3.3.1. Drivers

3.3.1.1. Increasing geriatric population

3.3.1.2. Advanced varicose vein treatment devices

3.3.1.3. Engagement in occupation that increases the prevalence of varicose vein treatment

3.3.1.4. Technological advancement

3.3.2. Restraints

3.3.2.1. Risk factors associated with the treatment devices and less experienced healthcare professionals

3.3.3. Opportunities

3.3.3.1. Increase in level of awareness

3.3.3.2. Untapped markets in emerging markets

3.3.4. Impact analysis

Chapter: 4: VARICOSE VEIN TREATMENT MARKET, BY PROCEDURE

4.1. Overview

4.1.1. Market size and forecast

4.2. Endovenous Ablation

4.2.1. Key trends and opportunities

4.2.2. Market size and forecast

4.2.3. Market analysis, by country

4.3. Injection Sclerotherapy

4.3.1. Key trends and opportunities

4.3.2. Market size and forecast

4.3.3. Market analysis, by country

4.4. Surgical Ligation/Stripping

4.4.1. Key trends and opportunities

4.4.2. Market size and forecast

4.4.3. Market analysis, by country

Chapter: 5: VARICOSE VEIN TREATMENT MARKET, BY PRODUCT

5.1. Overview

5.1.1. Market size and forecast

5.2. Ablation Devices

5.2.1. Market size and forecast

5.2.2. Market analysis, by country

5.2.2.1. Radiofrequency Ablation Devices

5.2.2.2. Laser ablation devices

5.2.2.3. Others

5.2.3. Sclerotherapy Injection

5.2.4. Market size and forecast

5.2.5. Market analysis, by country

5.2.6. Others

5.2.7. Market size and forecast

5.2.8. Market analysis, by country

Chapter: 6: VARICOSE VEIN TREATMENT MARKET, BY END USER

6.1. Overview

6.1.1. Market size and forecast

6.2. Hospitals

6.2.1. Market size and forecast

6.2.2. Market analysis, by country

6.3. Ambulatory Centers

6.3.1. Market size and forecast

6.3.2. Market analysis, by country

6.4. Clinics

6.4.1. Market size and forecast

6.4.2. Market analysis, by country

Chapter: 7: VARICOSE VEIN TREATMENT MARKET, BY REGION

7.1. Overview

7.1.1. Market size and forecast

7.2. North America

7.2.1. Key trends and opportunities

7.2.2. North America market size & forecast, by country

7.2.2.1. U.S. market size & forecast, by procedure

7.2.2.2. U.S. market size & forecast, by product

7.2.2.3. U.S. market size & forecast, by end user

7.2.2.4. Canada market size & forecast, by procedure

7.2.2.5. Canada market size & forecast, by product

7.2.2.6. Canada market size & forecast, by end user

7.2.2.7. Mexico market size & forecast, by procedure

7.2.2.8. Mexico market size & forecast, by Product

7.2.2.9. Mexico market size & forecast, by end user

7.2.3. North America market size & forecast, by procedure

7.2.4. North America market size & forecast, by product

7.2.5. North America market size & forecast, by end user

7.3. Europe

7.3.1. Key trends and opportunities

7.3.2. Europe market size & forecast for varicose vein treatment market, by country

7.3.2.1. Germany market size & forecast, by procedure

7.3.2.2. Germany market size & forecast, by product

7.3.2.3. Germany market size & forecast, by end user

7.3.2.4. France market size & forecast, by Procedure

7.3.2.5. France market size & forecast, by product

7.3.2.6. France market size & forecast, by end user

7.3.2.7. UK market size & forecast, by procedure

7.3.2.8. UK market size & forecast, by product

7.3.2.9. UK market size & forecast, by end user

7.3.2.10. Italy market size & forecast, by procedure

7.3.2.11. Italy market size & forecast, by product

7.3.2.12. Italy market size & forecast, by end user

7.3.2.13. Spain market size & forecast, by procedure

7.3.2.14. Spain market size & forecast, by product

7.3.2.15. Spain market size & forecast, by end user

7.3.2.16. Rest of Europe market size & forecast, by procedure

7.3.2.17. Rest of Europe market size & forecast, by product

7.3.2.18. Rest of Europe market size & forecast, by end user

7.3.3. Europe market size & forecast, by procedure

7.3.4. Europe market size & forecast, by product

7.3.5. Europe market size & forecast, by end user

7.4. Asia-Pacific

7.4.1. Key trends and opportunities

7.4.2. Asia-Pacific market size & forecast, by country

7.4.2.1. Japan market size & forecast, by procedure

7.4.2.2. Japan market size & forecast, by product

7.4.2.3. Japan market size & forecast, by end user

7.4.2.4. China market size & forecast, by procedure

7.4.2.5. China market size & forecast, by product

7.4.2.6. China market size & forecast, by end user

7.4.2.7. India market size & forecast, by procedure

7.4.2.8. India market size & forecast, by product

7.4.2.9. India market size & forecast, by end user

7.4.2.10. Australia market size & forecast, by procedure

7.4.2.11. Australia market size & forecast, by product

7.4.2.12. Australia market size & forecast, by end user

7.4.2.13. South Korea market size & forecast, by procedure

7.4.2.14. South Korea market size & forecast, by product

7.4.2.15. South Korea market size & forecast, by end user

7.4.2.16. Rest of Asia-Pacific market size & forecast, by procedure

7.4.2.17. Rest of Asia-Pacific market size & forecast, by product

7.4.2.18. Rest of Asia-Pacific market size & forecast, by end user

7.4.3. Asia-Pacific market size & forecast, by procedure

7.4.4. Asia-Pacific market size & forecast, by product

7.4.5. Asia-Pacific market size & forecast, by end user

7.5. LAMEA

7.5.1. Key trends and opportunities

7.5.2. LAMEA market size & forecast, by country

7.5.2.1. Brazil market size & forecast, by procedure

7.5.2.2. Brazil market size & forecast, by product

7.5.2.3. Brazil market size & forecast, by end user

7.5.2.4. South Africa market size & forecast, by procedure

7.5.2.5. South Africa market size & forecast, by product

7.5.2.6. South Africa market size & forecast, by end user

7.5.2.7. Saudi Arabia market size & forecast, by procedure

7.5.2.8. Saudi Arabia market size & forecast, by product

7.5.2.9. Saudi Arabia market size & forecast, by end user

7.5.2.10. Rest of LAMEA market size & forecast, by procedure

7.5.2.11. Rest of LAMEA market size & forecast, by product

7.5.2.12. Rest of LAMEA market size & forecast, by end user

7.5.3. LAMEA market size & forecast, by procedure

7.5.4. LAMEA market size & forecast, by product

7.5.5. LAMEA market size & forecast, by end user

Chapter: 8: COMPANY PROFILES

8.1. Angiodynamics Inc

8.1.1. Company overview

8.1.2. Company snapshot

8.1.3. Operating business segments

8.1.4. Product Portfolio

8.1.5. Business performance

8.2. Alma Lasers

8.2.1. Company overview

8.2.2. Company snapshot

8.2.3. Operating business segments

8.2.4. Product portfolio

8.2.5. Key strategic moves and developments

8.3. biolitec AG Untere Viaduktgasse

8.3.1. Company overview

8.3.2. Company snapshot

8.3.3. Operating business segments

8.3.4. Product portfolio

8.4. BTG International Ltd

8.4.1. Company overview

8.4.2. Company snapshot

8.4.3. Operating business segments

8.4.4. Product Portfolio

8.4.5. Business performance

8.5. Energist Ltd

8.5.1. Company overview

8.5.2. Company snapshot

8.5.3. Product Portfolio

8.6. Lumenis

8.6.1. Company overview

8.6.2. Company snapshot

8.6.3. Operating business segments

8.6.4. Product Portfolio

8.7. Medtronic

8.7.1. Company overview

8.7.2. Company snapshot

8.7.3. Operating business segments

8.7.4. Product portfolio

8.8. Sciton Inc

8.8.1. Company overview

8.8.2. Company snapshot

8.8.3. Operating business segments

8.8.4. Product Portfolio

8.9. Syneron Medical Ltd

8.9.1. Company overview

8.9.2. Company snapshot

8.9.3. Operating business segments

8.9.4. Product Portfolio

8.9.5. Key strategic moves and developments

8.10. WON TECH Co., Ltd

8.10.1. Company overview

8.10.2. Company snapshot

8.10.3. Operating business segments

8.10.4. Product Portfolio

TABLE 01. VARICOSE VEIN TREATMENT MARKET SEGMENTATION

TABLE 02. TOP INVESTMENT POCKETS

TABLE 03. TOP PLAYER POSITIONING, 2017

TABLE 04. IMPACT ANALYSIS

TABLE 05. GLOBAL VARICOSE VEIN TREATMENT MARKET, BY PROCEDURE, 2017–2025 ($MILLION)

TABLE 06. VARICOSE VEIN TREATMENT MARKET FOR ENDOVENOUS ABLATION, BY REGION, 2017-2025 ($MILLION)

TABLE 07. VARICOSE VEIN TREATMENT MARKET FOR INJECTION SCLEROTHERAPY, BY REGION, 2017–2025 ($MILLION)

TABLE 08. VARICOSE VEIN TREATMENT MARKET FOR SURGICAL LIGATION/STRIPPING, BY REGION, 2017–2025 ($MILLION)

TABLE 09. GLOBAL VARICOSE VEIN TREATMENT DEVICES MARKET, BY PRODUCT, 2017–2025 ($MILLION)

TABLE 10. VARICOSE VEIN TREATMENT DEVICES MARKET FOR ABLATION DEVICES, BY REGION, 2017–2025 ($MILLION)

TABLE 11. GLOBAL VARICOSE VEIN TREATMENT DEVICES MARKET FOR PRODUCT, BY TYPE, 2017–2025 ($MILLION)

TABLE 12. VARICOSE VEIN TREATMENT DEVICES MARKET FOR VENOUS CLOSURE PRODUCTS, BY REGION, 2017–2025 ($MILLION)

TABLE 13. VARICOSE VEIN TREATMENT DEVICES MARKET FOR VENOUS CLOSURE PRODUCTS, BY REGION, 2017–2025 ($MILLION)

TABLE 14. GLOBAL VARICOSE VEIN TREATMENT MARKET, BY END USER, 2017–2025 ($MILLION)

TABLE 15. GLOBAL VARICOSE VEIN TREATMENT MARKET FOR HOSPITALS, BY REGION, 2017–2025 ($MILLION)

TABLE 16. GLOBAL VARICOSE VEIN TREATMENT FOR AMBULATORY CENTERS, BY REGION, 2017–2025 ($MILLION)

TABLE 17. GLOBAL VARICOSE VEIN TREATMENT MARKET FOR CLINICS, BY REGION, 2017–2025 ($MILLION)

TABLE 18. VARICOSE VEIN TREATMENT MARKET, BY REGION, 2017–2025 ($MILLION)

TABLE 19. NORTH AMERICA VARICOSE VEIN TREATMENT MARKET, BY COUNTRY, 2017–2025 ($MILLION)

TABLE 20. U.S. VARICOSE VEIN TREATMENT MARKET, BY PROCEDURE, 2017–2025 ($MILLION)

TABLE 21. U.S. VARICOSE VEIN TREATMENT MARKET, BY PRODUCT, 2017–2025 ($MILLION)

TABLE 22. U.S. VARICOSE VEIN TREATMENT MARKET, BY END USER, 2017–2025 ($MILLION)

TABLE 23. CANADA VARICOSE VEIN TREATMENT MARKET, BY PROCEDURE, 2017–2025 ($MILLION)

TABLE 24. CANADA VARICOSE VEIN TREATMENT MARKET, BY PRODUCT, 2017–2025 ($MILLION)

TABLE 25. CANADA VARICOSE VEIN TREATMENT MARKET, BY END USER, 2017–2025 ($MILLION)

TABLE 26. MEXICO VARICOSE VEIN TREATMENT MARKET, BY PROCEDURE, 2017–2025 ($MILLION)

TABLE 27. MEXICO VARICOSE VEIN TREATMENT MARKET, BY PRODUCT, 2017–2025 ($MILLION)

TABLE 28. MEXICO VARICOSE VEIN TREATMENT MARKET, BY END USER, 2017–2025 ($MILLION)

TABLE 29. NORTH AMERICA VARICOSE VEIN TREATMENT MARKET, BY PROCEDURE, 2017–2025 ($MILLION)

TABLE 30. NORTH AMERICA VARICOSE VEIN TREATMENT MARKET, BY PRODUCT, 2017–2025 ($MILLION)

TABLE 31. NORTH AMERICA VARICOSE VEIN TREATMENT MARKET, BY END USER, 2017–2025 ($MILLION)

TABLE 32. EUROPE VARICOSE VEIN TREATMENT MARKET, BY COUNTRY, 2017–2025 ($MILLION)

TABLE 33. GERMANY VARICOSE VEIN TREATMENT MARKET, BY PROCEDURE, 2017–2025 ($MILLION)

TABLE 34. GERMANY VARICOSE VEIN TREATMENT MARKET, BY PRODUCT, 2017–2025 ($MILLION)

TABLE 35. GERMANY VARICOSE VEIN TREATMENT MARKET, BY END USER, 2017–2025 ($MILLION)

TABLE 36. FRANCE VARICOSE VEIN TREATMENT MARKET, BY PROCEDURE, 2017–2025 ($MILLION)

TABLE 37. FRANCE VARICOSE VEIN TREATMENT MARKET, BY PRODUCT, 2017–2025 ($MILLION)

TABLE 38. FRANCE VARICOSE VEIN TREATMENT MARKET, BY END USER, 2017–2025 ($MILLION)

TABLE 39. UK VARICOSE VEIN TREATMENT MARKET, BY PROCEDURE, 2017–2025 ($MILLION)

TABLE 40. UK VARICOSE VEIN TREATMENT MARKET, BY PRODUCT, 2017–2025 ($MILLION)

TABLE 41. UK VARICOSE VEIN TREATMENT MARKET, BY END USER, 2017–2025 ($MILLION)

TABLE 42. ITALY VARICOSE VEIN TREATMENT MARKET, BY PROCEDURE, 2017–2025 ($MILLION)

TABLE 43. ITALY VARICOSE VEIN TREATMENT MARKET, BY PRODUCT, 2017–2025 ($MILLION)

TABLE 44. ITALY VARICOSE VEIN TREATMENT MARKET, BY END USER, 2017–2025 ($MILLION)

TABLE 45. SPAIN VARICOSE VEIN TREATMENT MARKET, BY PROCEDURE, 2017–2025 ($MILLION)

TABLE 46. SPAIN VARICOSE VEIN TREATMENT MARKET, BY PRODUCT, 2017–2025 ($MILLION)

TABLE 47. SPAIN VARICOSE VEIN TREATMENT MARKET, BY END USER, 2017–2025 ($MILLION)

TABLE 48. REST OF EUROPE VARICOSE VEIN TREATMENT MARKET, BY PROCEDURE, 2017–2025 ($MILLION)

TABLE 49. REST OF EUROPE VARICOSE VEIN TREATMENT MARKET, BY PRODUCT, 2017–2025 ($MILLION)

TABLE 50. REST OF EUROPE VARICOSE VEIN TREATMENT MARKET, BY END USER, 2017–2025 ($MILLION)

TABLE 51. EUROPE VARICOSE VEIN TREATMENT MARKET, BY PROCEDURE, 2017–2025 ($MILLION)

TABLE 52. EUROPE VARICOSE VEIN TREATMENT MARKET, BY PRODUCT, 2017–2025 ($MILLION)

TABLE 53. EUROPE VARICOSE VEIN TREATMENT MARKET, BY END USER, 2017–2025 ($MILLION)

TABLE 54. ASIA-PACIFIC VARICOSE VEIN TREATMENT MARKET, BY COUNTRY, 2017–2025 ($MILLION)

TABLE 55. JAPAN VARICOSE VEIN TREATMENT MARKET, BY PROCEDURE, 2017–2025 ($MILLION)

TABLE 56. JAPAN VARICOSE VEIN TREATMENT MARKET, BY PRODUCT, 2017–2025 ($MILLION)

TABLE 57. JAPAN VARICOSE VEIN TREATMENT MARKET, BY END USER, 2017–2025 ($MILLION)

TABLE 58. CHINA VARICOSE VEIN TREATMENT MARKET, BY PROCEDURE, 2017–2025 ($MILLION)

TABLE 59. CHINA VARICOSE VEIN TREATMENT MARKET, BY PRODUCT, 2017–2025 ($MILLION)

TABLE 60. CHINA VARICOSE VEIN TREATMENT MARKET, BY END USER, 2017–2025 ($MILLION)

TABLE 61. INDIA VARICOSE VEIN TREATMENT MARKET, BY PROCEDURE, 2017–2025 ($MILLION)

TABLE 62. INDIA VARICOSE VEIN TREATMENT MARKET, BY PRODUCT, 2017–2025 ($MILLION)

TABLE 63. INDIA VARICOSE VEIN TREATMENT MARKET, BY END USER, 2017–2025 ($MILLION)

TABLE 64. AUSTRALIA VARICOSE VEIN TREATMENT MARKET, BY PROCEDURE, 2017–2025 ($MILLION)

TABLE 65. AUSTRALIA VARICOSE VEIN TREATMENT MARKET, BY PRODUCT, 2017–2025 ($MILLION)

TABLE 66. AUSTRALIA VARICOSE VEIN TREATMENT MARKET, BY END USER, 2017–2025 ($MILLION)

TABLE 67. SOUTH KOREA VARICOSE VEIN TREATMENT MARKET, BY PROCEDURE, 2017–2025 ($MILLION)

TABLE 68. SOUTH KOREA VARICOSE VEIN TREATMENT MARKET, BY PRODUCT, 2017–2025 ($MILLION)

TABLE 69. SOUTH KOREA VARICOSE VEIN TREATMENT MARKET, BY END USER, 2017–2025 ($MILLION)

TABLE 70. REST OF ASIA-PACIFIC VARICOSE VEIN TREATMENT PROCEDURE MARKET, BY PROCEDURE, 2017–2025 ($MILLION)

TABLE 71. REST OF ASIA-PACIFIC VARICOSE VEIN TREATMENT MARKET, BY PRODUCT, 2017–2025 ($MILLION)

TABLE 72. REST OF ASIA-PACIFIC VARICOSE VEIN TREATMENT MARKET, BY END USER, 2017–2025 ($MILLION)

TABLE 73. ASIA-PACIFIC VARICOSE VEIN TREATMENT MARKET, BY PROCEDURE, 2017–2025 ($MILLION)

TABLE 74. ASIA-PACIFIC VARICOSE VEIN TREATMENT MARKET, BY PRODUCT, 2017–2025 ($MILLION)

TABLE 75. ASIA-PACIFIC VARICOSE VEIN TREATMENT MARKET, BY END USER, 2017–2025 ($MILLION)

TABLE 76. LAMEA VARICOSE VEIN TREATMENT MARKET, BY COUNTRY, 2017–2025 ($MILLION)

TABLE 77. BRAZIL VARICOSE VEIN TREATMENT MARKET, BY PROCEDURE, 2017–2025 ($MILLION)

TABLE 78. BRAZIL VARICOSE VEIN TREATMENT MARKET, BY PRODUCT, 2017–2025 ($MILLION)

TABLE 79. BRAZIL VARICOSE VEIN TREATMENT MARKET, BY END USER, 2017–2025 ($MILLION)

TABLE 80. SOUTH AFRICA VARICOSE VEIN TREATMENT MARKET, BY PROCEDURE, 2017–2025 ($MILLION)

TABLE 81. SOUTH AFRICA VARICOSE VEIN TREATMENT MARKET, BY PRODUCT, 2017–2025 ($MILLION)

TABLE 82. SOUTH AFRICA VARICOSE VEIN TREATMENT MARKET, BY END USER, 2017–2025 ($MILLION)

TABLE 83. SAUDI ARABIA VARICOSE VEIN TREATMENT MARKET, BY PROCEDURE, 2017–2025 ($MILLION)

TABLE 84. SAUDI ARABIA VARICOSE VEIN TREATMENT MARKET, BY PRODUCT, 2017–2025 ($MILLION)

TABLE 85. SAUDI ARABIA VARICOSE VEIN TREATMENT MARKET, BY END USER, 2017–2025 ($MILLION)

TABLE 86. REST OF LAMEA VARICOSE VEIN TREATMENT MARKET, BY PROCEDURE, 2017–2025 ($MILLION)

TABLE 87. REST OF LAMEA VARICOSE VEIN TREATMENT MARKET, BY PRODUCT, 2017–2025 ($MILLION)

TABLE 88. REST OF LAMEA VARICOSE VEIN TREATMENT MARKET, BY END USER, 2017–2025 ($MILLION)

TABLE 89. LAMEA VARICOSE VEIN TREATMENT MARKET, BY PROCEDURE, 2017–2025 ($MILLION)

TABLE 90. LAMEA VARICOSE VEIN TREATMENT MARKET, BY PRODUCT, 2017–2025 ($MILLION)

TABLE 91. LAMEA VARICOSE VEIN TREATMENT MARKET, BY END USER, 2017–2025 ($MILLION)

TABLE 92. ANGIODYNAMICS INC: COMPANY SNAPSHOT

TABLE 93. ANGIODYNAMICS INC: OPERATING SEGMENTS

TABLE 94. ANGIODYNAMICS INC: PRODUCT PORTFOLIO

TABLE 95. ALMA LASERS: COMPANY SNAPSHOT

TABLE 96. ALMA LASERS: PRODUCT PORTFOLIO

TABLE 97. BIOLITEC AG: COMPANY SNAPSHOT

TABLE 98. BIOLITEC AG: OPERATING SEGMENTS

TABLE 99. BIOLITEC AG: PRODUCT PORTFOLIO

TABLE 100. BTG PLC: COMPANY SNAPSHOT

TABLE 101. BTG PLC: PRODUCT CATEGORY SEGMENTS

TABLE 102. BTG PLC: PRODUCT PORTFOLIO

TABLE 103. ENERGIST LTD: COMPANY SNAPSHOT

TABLE 104. ENERGIST LTD: PRODUCT PORTFOLIO

TABLE 105. LUMENIS.: COMPANY SNAPSHOT

TABLE 106. LUMENIS: PRODUCT PORTFOLIO

TABLE 107. MEDTRONIC: COMPANY SNAPSHOT

TABLE 108. MEDTRONIC: PRODUCT CATEGORIES

TABLE 109. MEDTRONIC: PRODUCT PORTFOLIO

TABLE 110. SCITON INC: COMPANY SNAPSHOT

TABLE 111. SCITON INC: OPERATING SEGMENTS

TABLE 112. SCITON INC: PRODUCT PORTFOLIO

TABLE 113. SYNERON MEDICAL: COMPANY SNAPSHOT

TABLE 114. SYNERON MEDICAL: PRODUCT CATEGORIES

TABLE 115. SYNERON MEDICAL: PRODUCT PORTFOLIO

TABLE 116. WONTECH CO. LTD: COMPANY SNAPSHOT

TABLE 117. WONTECH CO. LTD: OPERATING SEGMENTS

TABLE 117. WONTECH CO. LTD: PRODUCT PORTFOLIO